Bristol-Myers Squibb Co.

NYS : BMY
Pharmaceuticals
New York New York
2011 Revenue (US$ Millions)$21,244
2010 Revenue (US$ Millions)$19,484
Revenue Growth (%)9.03%
Net Income (US$ Millions)$3,709
Common Shares Outstanding (Millions)$1,690
Earnings Per Share (US$)$2.16
Earnings Per Share Growth (%)20.67%
Price To Earnings Ratio16.19
Total Equity (US$ Millions)$15,956
Profit Growth (%)19.57
Profit Margin (%)17.46%
Return On Equity (%)23.60%
Long Term Debt (US$ Millions)$5,376
Debt To Equity Ratio (%)0.34%
Market Capitalization (US$ Millions)$59,556
Total Assets (US$ Millions)$32,970
Return on Assets (%)11.94
Current Assets (US$ Millions)$15,318
Inventories (US$ Millions)$1,384
Current Liabilities (US$ Millions)$7,780
Cost of Goods Sold (US$ Millions)$5,598
Asset Turnover0.64
Inventory Turnover4.33